ATE292177T1 - Gentherapy von lungenkrankheiten - Google Patents
Gentherapy von lungenkrankheitenInfo
- Publication number
- ATE292177T1 ATE292177T1 AT00936206T AT00936206T ATE292177T1 AT E292177 T1 ATE292177 T1 AT E292177T1 AT 00936206 T AT00936206 T AT 00936206T AT 00936206 T AT00936206 T AT 00936206T AT E292177 T1 ATE292177 T1 AT E292177T1
- Authority
- AT
- Austria
- Prior art keywords
- genetherapy
- lung diseases
- inflammatory diseases
- pulmonary inflammatory
- viral
- Prior art date
Links
- 238000001415 gene therapy Methods 0.000 title abstract 2
- 208000019693 Lung disease Diseases 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 230000002685 pulmonary effect Effects 0.000 abstract 2
- 230000003612 virological effect Effects 0.000 abstract 2
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16233—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31807799A | 1999-05-25 | 1999-05-25 | |
| PCT/US2000/014146 WO2000071718A1 (en) | 1999-05-25 | 2000-05-23 | Gene therapy of pulmonary disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE292177T1 true ATE292177T1 (de) | 2005-04-15 |
Family
ID=23236541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00936206T ATE292177T1 (de) | 1999-05-25 | 2000-05-23 | Gentherapy von lungenkrankheiten |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1183361B1 (de) |
| JP (1) | JP2003500419A (de) |
| AT (1) | ATE292177T1 (de) |
| AU (1) | AU5155700A (de) |
| CA (1) | CA2373588A1 (de) |
| DE (1) | DE60019104D1 (de) |
| ES (1) | ES2235889T3 (de) |
| MX (1) | MXPA01012049A (de) |
| WO (1) | WO2000071718A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001042481A2 (en) * | 1999-12-07 | 2001-06-14 | Genethon Iii | Canine adenovirus vectors for the transfer of genes into target cells |
| JPWO2002066069A1 (ja) * | 2001-02-20 | 2004-09-24 | 関西ティー・エル・オー株式会社 | 炎症・腫瘍性疾患治療剤 |
| EP2097517B1 (de) | 2006-10-16 | 2014-06-04 | Genelux Corporation | Rekombinantes Lister-Stamm Vaccinia Virus kodierend für einen einzelkettigen anti-VEGF Antikörper |
| EP2986306A4 (de) | 2013-04-18 | 2016-12-07 | Armo Biosciences Inc | Verfahren zur verwendung von interleukin-10 zur behandlung von erkrankungen und leiden |
| JP7053453B2 (ja) | 2015-08-25 | 2022-04-12 | アルモ・バイオサイエンシーズ・インコーポレイテッド | 疾患及び障害を治療するためのインターロイキン10の使用方法 |
| CN115747214B (zh) * | 2022-07-12 | 2025-11-18 | 安徽理工大学 | Mlph基因在制备治疗尘肺病药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1013764A1 (de) * | 1994-07-05 | 2000-06-28 | Steeno Research Group A/S | Immunomodulatoren |
| CA2205076A1 (en) * | 1997-05-14 | 1998-11-14 | Jim Hu | Episomal expression cassettes for gene therapy |
-
2000
- 2000-05-23 DE DE60019104T patent/DE60019104D1/de not_active Expired - Lifetime
- 2000-05-23 AT AT00936206T patent/ATE292177T1/de not_active IP Right Cessation
- 2000-05-23 WO PCT/US2000/014146 patent/WO2000071718A1/en not_active Ceased
- 2000-05-23 ES ES00936206T patent/ES2235889T3/es not_active Expired - Lifetime
- 2000-05-23 AU AU51557/00A patent/AU5155700A/en not_active Abandoned
- 2000-05-23 CA CA002373588A patent/CA2373588A1/en not_active Abandoned
- 2000-05-23 MX MXPA01012049A patent/MXPA01012049A/es unknown
- 2000-05-23 EP EP00936206A patent/EP1183361B1/de not_active Expired - Lifetime
- 2000-05-23 JP JP2000620095A patent/JP2003500419A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000071718A1 (en) | 2000-11-30 |
| MXPA01012049A (es) | 2002-05-06 |
| EP1183361A1 (de) | 2002-03-06 |
| DE60019104D1 (de) | 2005-05-04 |
| ES2235889T3 (es) | 2005-07-16 |
| AU5155700A (en) | 2000-12-12 |
| EP1183361B1 (de) | 2005-03-30 |
| CA2373588A1 (en) | 2000-11-30 |
| JP2003500419A (ja) | 2003-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE231549T1 (de) | Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung | |
| EP1005376A4 (de) | Methoden und zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie | |
| IL122120A (en) | Recombinant mva virus containing a foreign gene inserted in a naturally occuring deletion within the genome | |
| EA200400376A1 (ru) | Пептиды, полученные из казеина, и их использование в терапии | |
| ATE500808T1 (de) | Onkolytische virustherapie | |
| DE69703689D1 (de) | Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia | |
| DK0661987T3 (da) | Morphogeninduceret leverregeneration | |
| DE69719754D1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| DE60038869D1 (de) | Hgf zur gentherapie der karidomyopathie | |
| ATE292177T1 (de) | Gentherapy von lungenkrankheiten | |
| MD990258A (en) | Method of treatment of the acute viral hepatitis B | |
| NO974179D0 (no) | Rekombinante viruser som uttrykker lecitin-kolesterol-acyltransferase, og anvendelse derav i genterapi | |
| NO954888L (no) | Farmasöytiske preparater og deres anvendelse, særlig for behandling av neuro-degenerative sykdommer | |
| AU2002364163A8 (en) | Use of dsrnas in strategic therapeutic intervention of highly active antiretroviral therapy | |
| NO961220D0 (no) | Farmasöytiske preparater og deres anvendelse, særlig for behandling av neuro-degenerative sykdommer | |
| DE69803052D1 (de) | Therapeutischer viraler wirkstoff, welcher das fortschreiten von tumoren stoppt | |
| NO964894L (no) | Rekombinante viruser, deres fremstilling samt anvendelse av genterapi | |
| WO2002038188A3 (de) | Verwendung der humanen lrp/mvp promotors für einen therapie-induzierbaren vektor | |
| FI20002612A0 (fi) | Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |